| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Oncology Institute, Inc. | Director | Common Stock | 5,444,207 | $25,097,794 | $4.61 | 18 Nov 2025 | Direct |
| Oncology Institute, Inc. | Director | Warrant to Purchase Shares of Common Stock | 1,358,449 | $169,806 | $0.1250 | 26 Mar 2025 | Direct |
| Oncology Institute, Inc. | Director | Common Stock | 0 | $0 | $4.61 | 18 Nov 2025 | Indirect |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| TOI | Oncology Institute, Inc. | 18 Nov 2025 | 3 | $0 | 4 | Director | 20 Nov 2025, 16:02 |
| TOI | Oncology Institute, Inc. | 04 Sep 2025 | 2 | -$20,703,000 | 4 | Director, 10%+ Owner | 05 Sep 2025, 06:12 |
| TOI | Oncology Institute, Inc. | 05 Jun 2025 | 2 | -$2,287,500 | 4 | Director, 10%+ Owner | 09 Jun 2025, 16:15 |
| TOI | Oncology Institute, Inc. | 20 May 2025 | 2 | -$5,425,800 | 4 | Director, 10%+ Owner | 22 May 2025, 19:38 |
| TOI | Oncology Institute, Inc. | 26 Mar 2025 | 2 | +$2,999,999 | 4 | Director, 10%+ Owner | 28 Mar 2025, 19:36 |
| TOI | Oncology Institute, Inc. | 12 Nov 2021 | 0 | $0 | 3 | 10%+ Owner | 22 Nov 2021, 15:38 |